Beraprost
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 50–70% |
Metabolism | Unknown |
Elimination half-life | 35–40 minutes |
Excretion | ? |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C24H30O5 |
Molar mass | 398.492 g/mol |
WikiDoc Resources for Beraprost |
Articles |
---|
Most recent articles on Beraprost |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Beraprost at Clinical Trials.gov Clinical Trials on Beraprost at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Beraprost
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Beraprost Discussion groups on Beraprost Directions to Hospitals Treating Beraprost Risk calculators and risk factors for Beraprost
|
Healthcare Provider Resources |
Causes & Risk Factors for Beraprost |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Beraprost is a synthetic analogue of prostacyclin, under clinical trials for the treatment of pulmonary hypertension. It is also being studied for use in avoiding reperfusion injury.
Clinical Pharmacology
As an analogue of prostacyclin PGI2, beraprost effects vasodilation, which in turn lowers the blood pressure. Beraprost also inhibits platelet aggregation, though the role this phenomenon may play in relation to pulmonary hypertension has yet to be determined.
Dosage and administration
Beraprost is administered orally as a pill.
References
- Pages with script errors
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Drug
- Cardiovascular Drugs
- Antiplatelet drugs
- Prostaglandins